(1R,3R)-5-((E)-2-((1R,3aS,7aR)-1-((R)-5-(cyclopropylamino)pentan-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-2-methylenecyclohexane-1,3-diol

ID: ALA3360785

PubChem CID: 71470821

Max Phase: Preclinical

Molecular Formula: C27H43NO2

Molecular Weight: 413.65

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1[C@H](O)CC(=C/C=C2\CCC[C@]3(C)[C@@H]([C@H](C)CCCNC4CC4)CC[C@@H]23)C[C@H]1O

Standard InChI:  InChI=1S/C27H43NO2/c1-18(6-5-15-28-22-10-11-22)23-12-13-24-21(7-4-14-27(23,24)3)9-8-20-16-25(29)19(2)26(30)17-20/h8-9,18,22-26,28-30H,2,4-7,10-17H2,1,3H3/b21-9+/t18-,23-,24+,25-,26-,27-/m1/s1

Standard InChI Key:  FLEHQRTTWKDNGI-WSGFCWAJSA-N

Molfile:  

     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
    7.4832  -11.3969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5878  -15.2483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5878  -16.0734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3004  -16.4796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0130  -16.0734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0130  -15.2483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3004  -14.8296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8734  -16.4848    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7275  -16.4848    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3004  -14.0046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0155  -13.5942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0155  -12.7692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0219  -11.1215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3050  -11.5307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3014  -12.3583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7352  -11.5357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7314  -12.3550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5097  -12.6146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9919  -11.9531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5157  -11.2874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7271  -13.1796    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    3.7271  -10.7086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7728  -10.5037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5806  -10.3366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2220   -9.8870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1313  -10.9532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9391  -10.7820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2935  -11.2315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3004  -17.3047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0767  -11.4902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9113  -10.6799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3108  -11.0693    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  2  7  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  3  8  1  6
  5  9  1  1
  7 10  2  0
 10 11  1  0
 11 12  2  0
 12 17  1  0
 12 15  1  0
 16 13  1  0
 13 14  1  0
 14 15  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 16  1  0
 17 21  1  6
 16 22  1  1
 20 23  1  0
 23 24  1  0
 23 25  1  6
 24 26  1  0
 26 27  1  0
 27  1  1  0
  1 28  1  0
  4 29  2  0
 30 28  1  0
 31 30  1  0
 28 31  1  0
 20 32  1  6
M  END

Associated Targets(Human)

CYP24A1 Tchem Cytochrome P450 24A1 (161 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 413.65Molecular Weight (Monoisotopic): 413.3294AlogP: 5.30#Rotatable Bonds: 7
Polar Surface Area: 52.49Molecular Species: BASEHBA: 3HBD: 3
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 10.30CX LogP: 4.23CX LogD: 1.49
Aromatic Rings: Heavy Atoms: 30QED Weighted: 0.39Np Likeness Score: 1.84

References

1. Ferla S, Aboraia AS, Brancale A, Pepper CJ, Zhu J, Ochalek JT, DeLuca HF, Simons C..  (2014)  Small-molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): synthesis and biological evaluation.,  57  (18): [PMID:25148392] [10.1021/jm5009314]
2. Bruno, Robert D RD and Njar, Vincent C O VC.  2007-08-01  Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.  [PMID:17544277]
3. Taban, Ismail M IM, Zhu, Jinge J, DeLuca, Hector F HF and Simons, Claire C.  2017-08-01  Synthesis, molecular modelling and CYP24A1 inhibitory activity of novel of (E)-N-(2-(1H-imidazol-1-yl)-2-(phenylethyl)-3/4-styrylbenzamides.  [PMID:28601511]

Source